CTLA-4 suppresses the pathogenicity of self antigen-specific T cells by cell-intrinsic and cell-extrinsic mechanisms
- PMID: 20037585
- PMCID: PMC3235641
- DOI: 10.1038/ni.1835
CTLA-4 suppresses the pathogenicity of self antigen-specific T cells by cell-intrinsic and cell-extrinsic mechanisms
Abstract
The inhibitory immunoregulatory receptor CTLA-4 is critical in maintaining self-tolerance, but the mechanisms of its actions have remained controversial. Here we examined the antigen specificity of tissue-infiltrating CD4(+) T cells in Ctla4(-/-) mice. After adoptive transfer, T cells isolated from tissues of Ctla4(-/-) mice showed T cell antigen receptor (TCR)-dependent accumulation in the tissues from which they were derived, which suggested reactivity to tissue-specific antigens. We identified the pancreas-specific enzyme PDIA2 as an autoantigen in Ctla4(-/-) mice. CTLA-4 expressed either on PDIA2-specific effector cells or on regulatory T cells was sufficient to control tissue destruction mediated by PDIA2-specific T cells. Our results demonstrate that both cell-intrinsic and non-cell-autonomous actions of CTLA-4 operate to maintain T cell tolerance to a self antigen.
Figures







Similar articles
-
CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance.J Exp Med. 2009 Feb 16;206(2):421-34. doi: 10.1084/jem.20081811. Epub 2009 Feb 2. J Exp Med. 2009. PMID: 19188497 Free PMC article.
-
Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.Annu Rev Immunol. 2001;19:225-52. doi: 10.1146/annurev.immunol.19.1.225. Annu Rev Immunol. 2001. PMID: 11244036 Review.
-
Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152).J Immunol. 2000 May 1;164(9):4433-42. doi: 10.4049/jimmunol.164.9.4433. J Immunol. 2000. PMID: 10779742
-
Nonself-antigens are the cognate specificities of Foxp3+ regulatory T cells.Immunity. 2007 Sep;27(3):493-504. doi: 10.1016/j.immuni.2007.07.019. Immunity. 2007. PMID: 17869133 Free PMC article.
-
Mechanisms of unresponsiveness: T- and B-cell mediated mechanisms of anergy.Adv Exp Med Biol. 2001;489:109-17. doi: 10.1007/978-1-4615-1277-6_10. Adv Exp Med Biol. 2001. PMID: 11554585 Review. No abstract available.
Cited by
-
CD4⁺ CD45RA⁻ FoxP3high activated regulatory T cells are functionally impaired and related to residual insulin-secreting capacity in patients with type 1 diabetes.Clin Exp Immunol. 2013 Aug;173(2):207-16. doi: 10.1111/cei.12116. Clin Exp Immunol. 2013. PMID: 23607886 Free PMC article.
-
Incidence of Hyper Progressive Disease in Combination Immunotherapy and Anti-Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Monotherapy for Unresectable Hepatocellular Carcinoma.Liver Cancer. 2023 May 11;13(1):56-69. doi: 10.1159/000531024. eCollection 2024 Feb. Liver Cancer. 2023. PMID: 38344443 Free PMC article.
-
T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance.Cell Death Dis. 2015 Mar 19;6(3):e1694. doi: 10.1038/cddis.2015.42. Cell Death Dis. 2015. PMID: 25789969 Free PMC article. Review.
-
A bispecific protein capable of engaging CTLA-4 and MHCII protects non-obese diabetic mice from autoimmune diabetes.PLoS One. 2013 May 21;8(5):e63530. doi: 10.1371/journal.pone.0063530. Print 2013. PLoS One. 2013. PMID: 23704916 Free PMC article.
-
Establishment of a novel platform cell line for efficient and precise evaluation of T cell receptor functional avidity.Oncotarget. 2018 Sep 25;9(75):34132-34141. doi: 10.18632/oncotarget.26139. eCollection 2018 Sep 25. Oncotarget. 2018. PMID: 30344927 Free PMC article.
References
-
- Alegre ML, Frauwirth KA, Thompson CB. T-cell regulation by CD28 and CTLA-4. Nat Rev Immunol. 2001;1:220–228. - PubMed
-
- Salomon B, Bluestone JA. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol. 2001;19:225–252. - PubMed
-
- Tivol EA, et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 1995;3:541–547. - PubMed
-
- Waterhouse P, et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science. 1995;270:985–988. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials